Archives

by in
Entry Author Date Location
Alkermes Scores Phase 3 Win for Long-Lasting Schizophrenia Drug 04/08/14 Boston
Adaptive Corrals $105M to Ramp up Immune System Diagnostics 04/07/14 Seattle
East Coast Biotech Roundup: Proteon, Ataxion, NY Genome/Watson, & More 03/21/14 Boston
Alder BioPharmaceuticals Hits IPO Trail Looking for $115M 03/19/14 Seattle
Five Prime, Bristol-Myers Squibb Cut $350M Immuno-Oncology Deal 03/17/14 San Francisco
East Coast Biotech Roundup: VentriNova, RainDance, Biogen, & More 03/07/14 Boston
Merck Joins ‘What’s Hot in Cancer Immunotherapy’ Apr. 22 03/04/14 Seattle
East Coast Biotech Roundup: Sigal, Radius, SHIN-NY, & More 02/28/14 Boston
Elliott Sigal, Bristol’s Former R&D Chief, on Life After Big Pharma 02/25/14 New York
Join Xconomy for ‘What’s Hot in Cancer Immunotherapy’ on April 22 02/20/14 Seattle
Immuno-Oncology Fever Rages as Novartis Snaps Up CoStim 02/18/14 Boston
East Coast Biotech Roundup: Genocea, Eleven, NIH/Pharma, & More 02/07/14 Boston
Social Media & Cancer Drugs: Conversation, not Promotion 01/23/14 Wisconsin
MD Anderson Expands “Moon Shots” Immunotherapy Partnership to J&J 01/21/14 Texas
Alkermes Nabs $250M It Doesn’t Need, But Could Fend Off Barbarians 01/13/14 Boston
Rock Health Honors “Top 50″ Digital Health Entrepreneurs 01/13/14 San Francisco
What Biotech Pros Will Be Chirping About at JP Morgan This Week 01/13/14 National
Houston’s MD Anderson Partners With Pfizer on Cancer Immunotherapies 01/08/14 Texas
East Coast Biotech Roundup: Curoverse, Sia, Trinity, & (Much) More 12/20/13 Boston
Hologic Names New CEO, Cuts Deal With Icahn to Avoid Proxy Fight 12/09/13 Boston
Juno Therapeutics Grabs $120M to Coax Immune System to Fight Cancer 12/03/13 Seattle
Armo BioSciences Joins the Cancer Immunotherapy Party With $20M 11/25/13 San Francisco
Hologic, Fending off Icahn, Adopts Poison Pill to Deflect Takeover 11/21/13 Boston
Dendreon Cuts 150 Jobs, As Prostate Cancer Drug Sales Decline 11/12/13 Seattle
Bristol-Myers Cuts Clinical Team at ZymoGenetics Seattle Site 11/07/13 Seattle
East Coast Biotech Roundup: Vertex, Dimension, Merrimack, & More 11/01/13 Boston
Immune Design Grabs $32.5M, Cashing in on Cancer Immunotherapy Rush 10/30/13 Seattle
Bristol-Myers, Alder Drug for Rheumatoid Arthritis Passes Key Test 10/28/13 Seattle
The Biggest Bargains Pharma Scooped Up in the Down Years 10/28/13 National
What Can Washington Do to Revitalize Biotech? Q&A With Gov. Inslee 10/25/13 Seattle
Page 1 of 9 next page »